Seeing Is Believing
Currently out of the existing stock ratings of Yanan Zhu, 104 are a BUY (75.36%), 34 are a HOLD (24.64%).
Analyst Yanan Zhu, currently employed at WELLS FARGO, carries an average stock price target met ratio of 42.46% that have a potential upside of 40.97% achieved within 98 days.
Yanan Zhu’s has documented 265 price targets and ratings displayed on 31 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on FATE, Fate Therapeutics at 14-Aug-2026.
Analyst best performing recommendations are on RGLS (REGULUS THERAPEUTICS).
The best stock recommendation documented was for QURE (UNIQURE NV) at 3/3/2026. The price target of $15 was fulfilled within 6 days with a profit of $5.97 (66.11%) receiving and performance score of 110.19.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-Nov-2017
$1150
$165.61 (16.82%)
$1150
7 days ago
(08-Sep-2026)
32/35 (91.43%)
$142.93 (14.19%)
125
Buy Since 03-Jul-2025
$1250
$265.61 (26.98%)
$1230
15 days ago
(31-Aug-2026)
2/4 (50%)
$218.34 (21.16%)
192
Hold Since 06-Nov-2023
$1400
$415.61 (42.22%)
$910
20 days ago
(26-Aug-2026)
7/8 (87.5%)
$352.9 (33.70%)
218
Buy Since 14-Sep-2018
$1415
$430.61 (43.74%)
$1260
20 days ago
(26-Aug-2026)
21/26 (80.77%)
$367.9 (35.14%)
204
Buy Since 25-Aug-2025
$1100
$115.61 (11.74%)
$1025
28 days ago
(18-Aug-2026)
6/7 (85.71%)
$107.01 (10.78%)
74
Which stock is Yanan Zhu most bullish on?
Which stock is Yanan Zhu most reserved on?
What Year was the first public recommendation made by Yanan Zhu?